Stoke Therapeutics (STOK) Net Margin (QoQ) (2022 - 2026)
Stoke Therapeutics (STOK) Net Margin (QoQ) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Stoke Therapeutics | 1.87 Bn | 1.53 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 365,061.00 |
| Dec 31, 2025 | -409,268.00 |
| Sep 30, 2025 | -19,072.00 |
| Jun 30, 2025 | -24,114.00 |
| Mar 31, 2025 | 13,638.00 |
| Dec 31, 2024 | 47,485.00 |
| Sep 30, 2024 | -817.00 |
| Jun 30, 2024 | 9,369.00 |
| Mar 31, 2024 | 518,346.00 |
| Dec 31, 2023 | -498,757.00 |
| Sep 30, 2023 | 67,358.00 |
| Jun 30, 2023 | -101,540.00 |
| Mar 31, 2023 | 333,150.00 |
| Dec 31, 2022 | -280,329.00 |
| Sep 30, 2022 | -1,169.00 |
| Jun 30, 2022 | -12,966.00 |